Peginterferon-lambda shows strong antiviral action to accelerate clearance of COVID-19

(University Health Network) A clinical study led by Dr. Jordan Feld, a liver specialist at Toronto Centre for Liver Disease, University Health Network (UHN), showed an experimental antiviral drug can significantly speed up recovery for COVID-19 outpatients - patients who do not need to be hospitalized.This could become an important intervention to treat infected patients and help curb community spread, while COVID-19 vaccines are rolled out this year.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news